However, when patients were simultaneously stratified according to EMT and PDCD1 status, we identified a statistically significant reduction in overall survival for patients with cancer cells having M/high PDCD1 signatures, relative to those with E/low-PDCD1 signatures (figure 7G). The gene discussed is PDCD1; the disease is cancer.